The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Martin C. Michel

Department of Pharmacology and Pharmacotherapy and Department of Urology

Academic Medical Center

University of Amsterdam



Name/email consistency: high



  • Department of Pharmacology and Pharmacotherapy and Department of Urology, Academic Medical Center, University of Amsterdam, Netherlands. 2004 - 2008


  1. Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study. Michel, M.C., Wetterauer, U., Vogel, M., de la Rosette, J.J. Drug. Saf (2008) [Pubmed]
  2. Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Michel, M.C., Barendrecht, M.M. Pharmacol. Ther. (2008) [Pubmed]
  3. Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients. Michel, M.C., Oelke, M., Goepel, M., Beck, E., Burkart, M. Neurourol. Urodyn. (2007) [Pubmed]
  4. Vascular effects of sphingolipids. Michel, M.C., Mulders, A.C., Jongsma, M., Alewijnse, A.E., Peters, S.L. Acta. Paediatr. Suppl (2007) [Pubmed]
  5. Ligand-directed signaling: 50 ways to find a lover. Michel, M.C., Alewijnse, A.E. Mol. Pharmacol. (2007) [Pubmed]
  6. Tolerability of amine uptake inhibitors in urologic diseases. Michel, M.C., Ruhe, H.G., de Groot, A.A., Castro, R., Oelke, M. Curr. Drug. Saf (2006) [Pubmed]
  7. Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL). Michel, M.C., Chapple, C.R. Eur. Urol. (2006) [Pubmed]
  8. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Michel, M.C., Vrydag, W. Br. J. Pharmacol. (2006) [Pubmed]
  9. In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits. Michel, M.C., Okutsu, H., Noguchi, Y., Suzuki, M., Ohtake, A., Yuyama, H., Yanai-Inamura, H., Ukai, M., Watanabe, M., Someya, A., Sasamata, M. Naunyn Schmiedebergs Arch. Pharmacol. (2006) [Pubmed]
  10. An anthology from Naunyn-Schmiedeberg's Archives of Pharmacology. Michel, M.C. Naunyn Schmiedebergs Arch. Pharmacol. (2006) [Pubmed]
  11. Transient receptor potential (TRP) channels as drug targets. Michel, M.C. Naunyn Schmiedebergs Arch. Pharmacol. (2006) [Pubmed]
  12. Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?. Michel, M.C., Hegde, S.S. Naunyn Schmiedebergs Arch. Pharmacol. (2006) [Pubmed]
  13. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Michel, M.C., de la Rosette, J.J., Piro, M., Schneider, T. Eur. Urol. (2005) [Pubmed]
  14. Role of muscarinic receptor antagonists in urgency and nocturia. Michel, M.C., de la Rosette, J.J. BJU Int. (2005) [Pubmed]
  15. Duloxetine in the treatment of stress urinary incontinence. Michel, M.C., Oelke, M. Women's. Health. (london,. England) (2005) [Pubmed]
  16. Efficacy and safety of tamsulosin in the treatment of urological diseases. Michel, M.C., de la Rosette, J.J. Expert. Opin. Pharmacother (2004) [Pubmed]
  17. Safety of telmisartan in patients with arterial hypertension : an open-label observational study. Michel, M.C., Bohner, H., Köster, J., Schäfers, R., Heemann, U. Drug. Saf (2004) [Pubmed]
  18. Role of serotonin and noradrenaline in stress urinary incontinence. Michel, M.C., Peters, S.L. BJU Int. (2004) [Pubmed]
  19. Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder?. Michel, M.C., de la Rosette, J.J., Piro, M., Goepel, M. J. Urol. (2004) [Pubmed]
  20. Association of hypertension with symptoms of benign prostatic hyperplasia. Michel, M.C., Heemann, U., Schumacher, H., Mehlburger, L., Goepel, M. J. Urol. (2004) [Pubmed]
WikiGenes - Universities